(JKI) iShares Morningstar Mid-Cap - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US4642884062 • Mid-Cap Value

JKI: Financials, Industrials, Consumer Goods, Healthcare, Technology

The iShares Morningstar Mid-Cap Value ETF (JKI) is designed to provide exposure to mid-capitalization U.S. equities that exhibit value characteristics. The fund seeks to replicate the performance of the Morningstar® US Mid Cap Broad Value IndexSM, which is comprised of stocks from mid-sized companies that demonstrate value traits. By focusing on this segment, the ETF offers investors a targeted way to access the mid-cap value universe, which historically has provided a balance between growth and stability.

The ETF typically invests at least 90% of its assets in securities from the underlying index, which includes depositary receipts that represent index holdings. The Morningstar® US Mid Cap Broad Value IndexSM employs a proprietary methodology to identify mid-cap companies with value characteristics, such as lower price-to-earnings ratios, higher dividend yields, and other fundamental metrics that align with value investing principles. This approach aims to capture the potential of undervalued mid-cap stocks that may offer long-term growth opportunities.

With total assets under management (AUM) of $658.12 million, the ETF provides a cost-effective and diversified way to gain exposure to the mid-cap value segment of the U.S. equity market. The fund is listed on the NASDAQ exchange under the ticker symbol JKI, making it easily accessible to investors seeking to incorporate mid-cap value exposure into their portfolios.

Looking ahead, the mid-cap value segment is poised to benefit from evolving market conditions. As interest rates fluctuate and economic cycles shift, value stocks, particularly in the mid-cap range, may regain favor as investors seek undervalued opportunities with potential for capital appreciation. Additionally, the ETFs focus on a broad index ensures diversification across industries, reducing exposure to sector-specific risks. While past performance is not indicative of future results, the structural integrity of the fund, combined with the enduring appeal of value investing, positions JKI as a viable option for investors seeking to capitalize on the mid-cap value premium over the long term.

Additional Sources for JKI ETF

JKI ETF Overview

Market Cap in USD 611m
Category Mid-Cap Value
TER 0.06%
IPO / Inception 2004-06-28

JKI ETF Ratings

Growth Rating -16.8
Fundamental -
Dividend Rating 40.3
Rel. Strength -7.04
Analysts -
Fair Price Momentum 64.51 USD
Fair Price DCF -

JKI Dividends

Dividend Yield 12m 2.56%
Yield on Cost 5y 1.62%
Annual Growth 5y 5.22%
Payout Consistency 57.2%

JKI Growth Ratios

Growth Correlation 3m -88.1%
Growth Correlation 12m 35.4%
Growth Correlation 5y -19.1%
CAGR 5y -9.16%
CAGR/Max DD 5y -0.13
Sharpe Ratio 12m -0.63
Alpha -7.45
Beta 0.753
Volatility 33.74%
Current Volume 37.2k
Average Volume 20d 35.6k
What is the price of JKI stocks?
As of April 28, 2025, the stock is trading at USD 71.32 with a total of 37,197 shares traded.
Over the past week, the price has changed by +4.53%, over one month by -4.07%, over three months by -7.78% and over the past year by +1.01%.
Is iShares Morningstar Mid-Cap a good stock to buy?
Neither. Based on ValueRay Analyses, iShares Morningstar Mid-Cap is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -16.81 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JKI as of April 2025 is 64.51. This means that JKI is currently overvalued and has a potential downside of -9.55%.
Is JKI a buy, sell or hold?
iShares Morningstar Mid-Cap has no consensus analysts rating.
What are the forecast for JKI stock price target?
According to ValueRays Forecast Model, JKI iShares Morningstar Mid-Cap will be worth about 72.3 in April 2026. The stock is currently trading at 71.32. This means that the stock has a potential upside of +1.43%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 72.3 1.4%